NCT04752644View on ClinicalTrials.gov

Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

June 17, 2021

Study Completion Date

November 2, 2021

Conditions
RSV Infection
Interventions
BIOLOGICAL

MVA-mBN294B

MVA-BN-RSV (nominal titre 5 x10\*8 Inf.U per 0.5 mL) as intramuscular injections. Liquid frozen suspension, single dose of 0.5ml.

DRUG

Placebo

TBS (Placebo) as intramuscular injections (0.5ml)

Trial Locations (1)

E1 2AX

hVIVO Services Limited, London

Sponsors

Lead Sponsor

Bavarian Nordic
All Listed Sponsors
lead

Bavarian Nordic

INDUSTRY